Basit grafik
Gelişmiş program
Tanım Tema Obesity & Cardiometabolic ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.| Assets class size | Multi-Cap |
|---|---|
| Country | USA |
| Country ISO | US |
| Focus | Health Care |
| Issuer | Dawn Global Topco Ltd. |
| Region specific | Broad |
| Segment | Equity: Global Pharma, Biotech & Life Sciences |
| Strategy | Active |
| Валюта | usd |
| Годовая доходность | 27 |
| Дата основания | Nov 21. 2023 |
| Индекс | ACTIVE - No Index |
| Код ценной бумаги | HRTS |
| Количество компаний | 10 |
| Комиссия | 0.75 |
| Объем | 59531088 |
| Полное наименование | Tema Obesity & Cardiometabolic ETF |
| Регион | Global |
| Сайт | bağlantı |
| Средний P/E | 16.57 |
| Тип актива | Equity |
| Günlük fiyat değişimi: | 0% (29.87) |
|---|---|
| Haftalık fiyat değişimi: | +4.08% (28.7) |
| Aylık fiyat değişimi: | +0.776% (29.64) |
| 3 ayda fiyat değişimi: | -10.41% (33.34) |
| Altı ayda fiyat değişimi: | -12.97% (34.32) |
| Yılbaşından bu yana fiyat değişimi: | +2.47% (29.15) |
Aboneliğiniz için ödeme yapın
Abonelik yoluyla şirket ve portföy analizi için daha fazla işlevsellik ve veri elde edilebilir
| İsim | Endüstri | Paylaşmak, % | P/BV | P/S | P/E | EV/Ebitda | Temettü getirisi |
|---|---|---|---|---|---|---|---|
 Amgen |
Healthcare | 7.08994 | 24.53 | 5.42 | 22.76 | 26.16 | 3.01 |
 Eli Lilly and Company |
Healthcare | 5.52241 | 47.43 | 15.1 | 98.32 | 43.16 | 0.6064 |
 Alnylam Pharmaceuticals, Inc. |
Healthcare | 5.30214 | -108.14 | 13.05 | 0 | -112.79 | 0 |
 Vertex |
Healthcare | 4.44564 | 6 | 10.73 | 29.17 | 24.42 | 0 |
 BridgeBio Pharma, Inc. |
Healthcare | 4.07181 | -5.09 | 734.78 | 0 | -14.27 | 0 |
 Chugai Pharmaceutical Co., Ltd. |
Healthcare | 3.73691 | 5.41 | 7.92 | 27.04 | 18.68 | 2.14 |
 Ultragenyx Pharmaceutical Inc. |
Healthcare | 3.46775 | 12.68 | 8.04 | 0 | -6.43 | 0 |
 Cytokinetics, Incorporated |
Healthcare | 3.31875 | -11.14 | 571.71 | 0 | -10.22 | 0 |
 AstraZeneca PLC |
Healthcare | 3.14097 | 5.29 | 4.52 | 34.78 | 16.52 | 1.93 |
